KR101420564B1 - ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ - Google Patents

ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ Download PDF

Info

Publication number
KR101420564B1
KR101420564B1 KR1020130010233A KR20130010233A KR101420564B1 KR 101420564 B1 KR101420564 B1 KR 101420564B1 KR 1020130010233 A KR1020130010233 A KR 1020130010233A KR 20130010233 A KR20130010233 A KR 20130010233A KR 101420564 B1 KR101420564 B1 KR 101420564B1
Authority
KR
South Korea
Prior art keywords
tgf
shrna
seq
adenovirus
expression
Prior art date
Application number
KR1020130010233A
Other languages
English (en)
Korean (ko)
Other versions
KR20130088792A (ko
Inventor
송재진
김주항
오세은
Original Assignee
연세대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 연세대학교 산학협력단 filed Critical 연세대학교 산학협력단
Priority to JP2014555484A priority Critical patent/JP2015506696A/ja
Priority to CN201380007620.1A priority patent/CN104245936B/zh
Priority to PCT/KR2013/000791 priority patent/WO2013115579A1/ko
Publication of KR20130088792A publication Critical patent/KR20130088792A/ko
Application granted granted Critical
Publication of KR101420564B1 publication Critical patent/KR101420564B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020130010233A 2012-01-31 2013-01-30 ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ KR101420564B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2014555484A JP2015506696A (ja) 2012-01-31 2013-01-31 ＴＧＦ−β２発現を抑制するｓｈＲＮＡ
CN201380007620.1A CN104245936B (zh) 2012-01-31 2013-01-31 用于抑制TGF-β2表达的shRNA
PCT/KR2013/000791 WO2013115579A1 (ko) 2012-01-31 2013-01-31 ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120009811 2012-01-31
KR1020120009811 2012-01-31

Publications (2)

Publication Number Publication Date
KR20130088792A KR20130088792A (ko) 2013-08-08
KR101420564B1 true KR101420564B1 (ko) 2014-07-17

Family

ID=49215002

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130010233A KR101420564B1 (ko) 2012-01-31 2013-01-30 ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ

Country Status (3)

Country Link
JP (1) JP2015506696A (zh)
KR (1) KR101420564B1 (zh)
CN (1) CN104245936B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101713407B1 (ko) * 2014-03-31 2017-03-07 연세대학교 산학협력단 아데노바이러스 감염 및 복제가 가능한 흑색종 세포주
WO2015152609A1 (ko) * 2014-03-31 2015-10-08 연세대학교 산학협력단 ＧＭ－ＣＳＦ 유전자; 데코린 유전자; ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ; 및 ＦｏｘＰ３ 발현을 억제하는 ｓｈＲＮＡ를 포함하는 항종양 조성물
JP6898325B2 (ja) * 2015-12-08 2021-07-07 ユニバーシティ−インダストリー・ファンデーション・ヨンセイ・ユニバーシティ ＧＭ−ＣＳＦ遺伝子；Ｆｌｔ３Ｌ−ＴＲＡＩＬ融合遺伝子；ＴＧＦ−βの発現を抑制するｓｈＲＮＡ；およびＨＳＰ発現を抑制するｓｈＲＮＡを含む抗腫瘍組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2674210A1 (en) * 2005-12-30 2007-07-12 Intradigm Corporation Sirna compositions promoting scar-free wound healing of skin and methods for wound treatment
WO2011154542A1 (en) * 2010-06-11 2011-12-15 Artisense Pharma Gmbh Method for selective oligonucleotide modification
CN101974529B (zh) * 2010-09-21 2013-04-03 南京大学（苏州）高新技术研究院 含自由三磷酸基团的TGF-β特异性siRNA及其应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Chenyu Zhang 등. Cancer Research. Vol. 69, No. 3, 페이지 828- 835 (2009.) *
GenBank Accession Number NM_001135599 (2010.12.19.) *
GenBank Accession Number NM_009367 (2010.12.29.) *

Also Published As

Publication number Publication date
KR20130088792A (ko) 2013-08-08
CN104245936B (zh) 2016-04-06
JP2015506696A (ja) 2015-03-05
CN104245936A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
EP1799826B1 (en) siRNA-MEDIATED GENE SILENCING OF ALPHA SYNUCLEIN
US7148342B2 (en) Compositions and methods for sirna inhibition of angiogenesis
US20100086526A1 (en) Nucleic acid constructs and methods for specific silencing of h19
US9222090B2 (en) RNA interference target for treating AIDS
CN111876421A (zh) 靶向KrasG12D突变转录本的gRNA序列、载体及其应用
WO2009100955A1 (en) Antisense rna targeting cxcr4
KR101420564B1 (ko) ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ
US20140275221A1 (en) Targeting of mirna precursors
WO2016030501A1 (en) Synthetic alu-retrotransposon vectors for gene therapy
US20230383275A1 (en) Sgrna targeting aqp1 rna, and vector and use thereof
JP2008048621A (ja) キメラ型アデノウイルスとその作製方法並びにそれを用いた医薬
KR101286053B1 (ko) ＴＧＦ－β１ 발현을 억제하는 ｓｈＲＮＡ
KR20180012255A (ko) 이영양성 수포성 표피박리증 치료를 위한 안티센스 올리고뉴클레오타이드
KR101374585B1 (ko) ＨＳＰ２７ 발현을 억제하는 ｓｈＲＮＡ
KR101683964B1 (ko) Daxx의 발현을 억제하는 핵산 분자, TRAIL 유전자 및 Bcl-xL 의 발현을 억제하는 핵산 분자를 포함하는 재조합 발현 벡터
EP2128261A1 (en) A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof
US20090060889A1 (en) Ii-RNAi involved Ii suppression in cancer immunotherapy
WO2013115579A1 (ko) ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ
WO2024078345A1 (zh) snRNA核酸分子及其应用
WO2023134560A1 (zh) 一种核苷酸及其应用
JP4505566B2 (ja) 肺癌治療剤
KR100627377B1 (ko) 뇌하수체 종양-형질전환 유전자 1 단백질의 합성을 차단할수 있는 작은 간섭 ｒｎａ 및 이를 발현하는 벡터를 이용한 암의 유전자 치료
WO2023191631A1 (en) Antisense nucleic acids for use in the treatment for lmna mutation carriers
KR20240034143A (ko) 신규한 유전체 세이프 하버 및 이의 용도
CN117778474A (zh) 一种基于CRISPR-Cas13a靶向敲低癌基因的表达载体及其应用

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20180702

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190701

Year of fee payment: 6